Atlas Trials

Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer

Clinical trial NCT04730999 · COMPLETED

Trial details

NCT number
NCT04730999
Sponsor
Gruppo Oncologico Italiano di Ricerca Clinica
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2020-07-01
Primary completion
2023-06-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.